Medicine
Cefoxitin 2 g powder for injection
Cefoxitin 2 g powder for injection is a generic prescription medicine for intravenous use, made by 4 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Special storage instructions Cefoxitin for Injection, USP in the dry state…
Key facts
- Active ingredient (INN)
- Cefoxitin
- Brand
- Sold under the generic name
- Strength
- 2 g
- Dosage form
- Powder for injection
- Route
- Intravenous
- Packs
- 25 vials, 10 vials and 3 more
- Manufacturers
- Fresenius KabiWG Critical CareHikma PharmaceuticalsSagent Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Special storage instructions Cefoxitin for Injection, USP in the dry state should be stored between 2º to 25ºC (36º to 77ºF). Avoid exposure to temperatures above 50ºC. The dry material as well as solutions tend to darken, depending on storage conditions, product potency, however, is not adversely affected.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J01DC01 Cefoxitin
- HS code (indicative)
- 3004.20Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 5 November 2009
- Identifiers
- RxCUI 1665102, 1665107DailyMed set ID 658a0dc6-6da5-44dc-94f2-1211619297f7, d02170ff-65aa-48b8-a922-94271c46ffa7, 91ac4c14-8dd8-4efe-a462-d1c488a6184f +3NDC 44567-246, 63323-342, 25021-110 +1Application ANDA065414, ANDA065238
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 25 vial in 1 carton / 1 powder, for solution in 1 vial | 63323-342-25 | Fresenius Kabi | 6 July 2011 |
| 25 vial in 1 carton / 1 powder, for solution in 1 vial | 63323-342-29 | Fresenius Kabi | 6 July 2011 |
| 25 vial in 1 carton / 1 injection, powder, for solution in 1 vial | 44567-246-25 | WG Critical Care | 18 February 2015 |
| 25 vial in 1 carton / 1 injection, powder, for solution in 1 vial | 44567-246-85 | WG Critical Care | 10 July 2017 |
| 25 vial in 1 carton / 1 injection, powder, for solution in 1 vial | 0143-9877-25 | Hikma Pharmaceuticals | 12 March 2010 |
| 10 vial in 1 carton / 1 injection, powder, for solution in 1 vial | 25021-110-20 | Sagent Pharmaceuticals | 5 November 2009 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 18 October 1978 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Cefoxitin
Clinical summary
Cefoxitin is a cephalosporin antibacterial indicated for the treatment of infections caused by susceptible isolates of the designated bacteria, among other approved uses. It is available as powder for injection and injection for intravenous use. MedsAcross supplies Cefoxitin for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about CefoxitinFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Cefoxitin and Dextrose prescribing information (B. Braun Medical) · U.S. National Library of Medicine, DailyMed
Need Cefoxitin 2 g powder for injection for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.